Kedar Purushottam Phadke
No más puestos en curso
Historial de carrera de Kedar Purushottam Phadke
Antiguos cargos conocidos de Kedar Purushottam Phadke.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| THERMAX LIMITED | Oficial de Cumplimiento | 08/08/2017 | 19/08/2021 |
| Contacto de Relaciones con Inversores | 08/08/2017 | 19/08/2021 | |
| Secretario Corporativo | 08/08/2017 | 19/08/2021 | |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Secretario Corporativo | 19/11/2010 | - |
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Consejero General | 01/12/2009 | - |
| Secretario Corporativo | 01/12/2009 | - |
Estadísticas
Internacional
| India | 4 |
Operativa
| Corporate Secretary | 3 |
| General Counsel | 1 |
| Compliance Officer | 1 |
Sectorial
| Producer Manufacturing | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Producer Manufacturing |
| THERMAX LIMITED | Producer Manufacturing |
| Empresas privadas | 1 |
|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
